查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
寡核甘酸合成市場:各oligo長度，各用途，各產品預測 - 附執行和顧問指南(2023年～2027年)
市場調查報告書
商品編碼
1309754

寡核甘酸合成市場:各oligo長度，各用途，各產品預測 - 附執行和顧問指南(2023年～2027年)

Oligonucleotide Synthesis Markets. Forecasts by Oligo Length, Application, and Product. With Executive and Consultant Guides. 2023 to 2027
出版日期: | 出版商: Howe Sound Research | 英文 352 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球寡核甘酸合成市場相關調查，提供市場概要，以及各oligo長度，各用途，各產品趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

第3章 寡核甘酸合成

  • 合成技術
  • 自動化
  • 寡核?酸的類型
  • PCR 引物
  • PCR 測定和麵板
  • 排序
  • DNA 微陣列
  • 熒光原位雜交（FISH）
  • 反義寡核?酸
  • 寡核?酸的其他用途
  • 與 CRISPR 和基因編輯的關係

第4章 產業概要

  • 市場進入組織
    • 學術研究機關
    • 診斷測試開發商
    • 儀器供應商
    • 藥品·試劑廠商
    • 病理供應商
    • 獨立型臨床檢驗室
    • 公共的國立/地區研究所
    • 醫院檢驗室
    • 臨床檢驗室
    • 審核機關
    • 認證機關

第5章 市場要素

  • 成長促進因素
  • 阻礙成長的要素
  • 今後5年

第6章 寡核甘酸合成的最近開發

第7章 主要企業簡介

  • Abbott Laboratories
  • Ajinomoto Bio-Pharma
  • Alnylam Pharmaceuticals
  • Amyris
  • Ansa BioTechnologies
  • ATDBio
  • ATG:biosynthetics
  • ATUM
  • Bayer
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Biomatik
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Synthesis
  • Blue Heron Biotechnology(Eurofins Genomic)
  • Camena Bioscience
  • Cepheid(Danaher)
  • Codexis
  • Diasorin S.p.A.
  • DNA Script
  • Enzo Biochem
  • Eurofins Scientific
  • Eurogentec(Kaneka)
  • Evonetix
  • GE Healthcare
  • Genomatica
  • Genscript Biotech
  • Hologic
  • Integrated DNA Technologies(Danaher)
  • Ionis Pharmaceuticals
  • Janssen Diagnostics
  • Kern Systems
  • LGC Biosearch Technologies
  • Maravai LifeSciences Holdings
  • Merck & Co., Inc
  • Microsynth
  • Millipore Sigma
  • Molecular Assemblies
  • New England Biolabs, Inc.
  • Nitto Denko(Avecia)
  • Nuclera
  • Primerdesign(Novacyt)
  • Qiagen
  • Revvity
  • Roche Molecular Diagnostics
  • Seegene
  • Siemens Healthineers
  • Synthego
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience

第8章 全球寡核甘酸合成市場概要

  • 各國全球市場概要
  • 不同長度的全球市場規模- 概要
  • 各用途的全球市場規模- 概要
  • 各產品的全球市場規模- 概要

第9章 全球市場，不同長度

  • 20 不滿mer
  • 21～50mer
  • 51～100mer
  • 100mer超

第10章 全球市場，各用途

  • 研究
  • 診斷
  • 治療
  • 資料

第11章 全球市場，各產品

  • 寡核甘酸
  • 設備
  • 試劑

第12章 附錄

OVERVIEW:

Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, Data Storage! We are not kidding. The market for small snippets of DNA, called Oligonucleotides, is growing into a market for Synthetic DNA where organisms, like algae, are "custom designed" to produce food and medicine while consuming few resources. In applications like CRSPR Gene Editing and COVID-19 Synthetic Antibodies these "Oligos" are already going to work. The possibilities, and market growth are unlimited. Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity. Small biotechs are in a position to become huge multinationals, all based on producing DNA and its building blocks. Learn all about it and see our forecasts in this comprehensive report.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast. It is coming out of the lab and onto the desktop as genetics crosses the chasm into mainstream commerce.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What is Oligonucleotide Synthesis?
    • 2.1.1 The Enzyme Race
    • 2.1.2 Data Storage - The Elephant in the Room
  • 2.2 Market Definition
    • 2.2.1 Market Size
    • 2.2.2 Currency
    • 2.2.3 Years
  • 2.3 Methodology
    • 2.3.1 Methodology
    • 2.3.2 Sources
    • 2.3.3 Authors
  • 2.4 Perspective: Healthcare and the IVD Industry
    • 2.4.1 Global Healthcare Spending
    • 2.4.2 Spending on Diagnostics
    • 2.4.3 Important Role of Insurance for Diagnostics

3 Oligonucleotide Synthesis

  • 3.1 Synthesis Technology
  • 3.2 Automation
  • 3.3 Types of Oligonucleotides
  • 3.4 PCR Primers
  • 3.5 PCR Assays and Panels
  • 3.6 Sequencing
  • 3.7 DNA Microarrays
  • 3.8 Fluorescence In Situ Hybridization (FISH)
  • 3.9 Antisense Oligonucleotides
  • 3.10 Other Uses of Oligonucleotides
  • 3.11 Relationship to CRISPR and Gene Editing

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Instrumentation Supplier
    • 4.1.4 Chemical/Reagent Supplier
    • 4.1.5 Pathology Supplier
    • 4.1.6 Independent Clinical Laboratory
    • 4.1.7 Public National/regional Laboratory
    • 4.1.8 Hospital Laboratory
    • 4.1.9 Physicians Office Lab (POLS)
    • 4.1.10 Audit Body
    • 4.1.11 Certification Body

5 Market Factors

  • 5.1 Factors Driving Growth
    • 5.1.1 The Role of Diagnostics and the Covid Effect
    • 5.1.2 The RNA Based Vaccine
    • 5.1.3 Genomic Blizzard
    • 5.1.4 Antisense Revival
    • 5.1.5 New Applications
  • 5.2 Factors Limiting Growth
    • 5.2.1 Declining Price
    • 5.2.2 Technology Lag
    • 5.2.3 COVID Realignment
  • 5.3 The Next Five Years

6 Oligonucleotide Synthesis Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Oligonucleotide Synthesis Scaled Up
  • 6.3 Antisense Oligonucleotide Lowers Tau Tangles
  • 6.4 Ansa Biotechnologies Synthesizes Longest Oligo at 1005 Bases
  • 6.5 Agilent will double oligonucleotide capacity
  • 6.6 RNA Synthesis Technology Commercialized by EnPlusOne
  • 6.7 Quick and Automated Printing of Custom Oligos
  • 6.8 WuXi STA Opens Large-Scale Oligo Manufacturing Facility
  • 6.9 Secarna Pharmaceuticals' and Evotec Achieve Programme Designation
  • 6.10 Aligos Discontinues Development of its Antisense Oligonucleotide
  • 6.11 Seegene Obtains CE Mark for Oligo Based SARS-CoV-2 Assay
  • 6.12 Biofidelity to Launch Mutation Detection Assay
  • 6.13 Oligonucleotide Therapeutics Society Holds Meeting
  • 6.14 New Oligonucleotide Synthesis Chemistry
  • 6.15 Antisense Oligonucleotides Cross Rodents' Blood-Brain Barrier
  • 6.16 New Rapid Multiplexed PCR Assay Uses Oligo Probes
  • 6.17 MIT Devises Oligo 'File System' for DNA Data Storage
  • 6.18 Nuclera Acquires E Ink Digital Microfluidics Business
  • 6.19 Twist Bioscience Hits Milestone for DNA Data Storage
  • 6.20 Twist Bioscience, Vivlion Partner on RNA Libraries for CRISPR
  • 6.21 DNA Script Launching Benchtop Synthesizer for 'DNA on Demand'
  • 6.22 RNA Disease Dx to Develop PoC Covid Test
  • 6.23 Evonetix and Analog Devices Develop GEN3 DNA Synthesis Platform
  • 6.24 ATDBio Receives Grant for Cancer Diagnosis Project
  • 6.25 Twist Bioscience Announces SARS-CoV-2 Therapeutic Ab
  • 6.26 Drugmakers boost oligo capacity amid Covid-19
  • 6.27 Aligos Therapeutics in Study of Oligo Candidate
  • 6.28 DNA Script Raises $89M for SYNTAX Launch
  • 6.29 Codexis & Molecular Assemblies Partner for DNA Synthesis
  • 6.30 NuProbe Licenses Oligo Technology from Rice
  • 6.31 Genome editing with Cas9-oligo conjugates
  • 6.32 OliX Pharma and AM Chemicals Partner for RNA Synthesis Support
  • 6.33 Twist Bio To End Trade Secrets Suit
  • 6.34 DNA Script, partners get grant for data storage
  • 6.35 Xi's STA unit opens oligonucleotide plant

7 Profiles of Key Companies

  • 7.1 Abbott Laboratories
  • 7.2 Ajinomoto Bio-Pharma
  • 7.3 Alnylam Pharmaceuticals
  • 7.4 Amyris
  • 7.5 Ansa BioTechnologies
  • 7.6 ATDBio
  • 7.7 ATG:biosynthetics
  • 7.8 ATUM
  • 7.9 Bayer
  • 7.10 Beckman Coulter Diagnostics
  • 7.11 Becton, Dickinson and Company
  • 7.12 Biomatik
  • 7.13 bioMérieux Diagnostics
  • 7.14 Bioneer Corporation
  • 7.15 Bio-Rad Laboratories, Inc.
  • 7.16 Bio-Synthesis
  • 7.17 Blue Heron Biotechnology (Eurofins Genomic)
  • 7.18 Camena Bioscience
  • 7.19 Cepheid (Danaher)
  • 7.20 Codexis
  • 7.21 Diasorin S.p.A.
  • 7.22 DNA Script
  • 7.23 Enzo Biochem
  • 7.24 Eurofins Scientific
  • 7.25 Eurogentec (Kaneka)
  • 7.26 Evonetix
  • 7.27 GE Healthcare
  • 7.28 Genomatica
  • 7.29 Genscript Biotech
  • 7.30 Hologic
  • 7.31 Integrated DNA Technologies (Danaher)
  • 7.32 Ionis Pharmaceuticals
  • 7.33 Janssen Diagnostics
  • 7.34 Kern Systems
  • 7.35 LGC Biosearch Technologies
  • 7.36 Maravai LifeSciences Holdings
  • 7.37 Merck & Co., Inc
  • 7.38 Microsynth
  • 7.39 Millipore Sigma
  • 7.40 Molecular Assemblies
  • 7.41 New England Biolabs, Inc.
  • 7.42 Nitto Denko (Avecia)
  • 7.43 Nuclera
  • 7.44 Primerdesign (Novacyt)
  • 7.45 Qiagen
  • 7.46 Revvity
  • 7.47 Roche Molecular Diagnostics
  • 7.48 Seegene
  • 7.49 Siemens Healthineers
  • 7.50 Synthego
  • 7.51 Thermo Fisher Scientific Inc.
  • 7.52 Twist Bioscience

8 Oligonucleotide Synthesis Global Market Overview

  • 8.1 Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market Size by Length - Overview
    • 8.2.1 Table - Global Market by Length
    • 8.2.2 Chart - Global Market by Length - Base/Final Year Comparison
    • 8.2.3 Chart - Global Market by Length - Base Year
    • 8.2.4 Chart - Global Market by Length - Final Year
    • 8.2.5 Chart - Global Market by Length - Share by Year
    • 8.2.6 Chart - Global Market by Length - Segment Growth
  • 8.3 Global Market Size by Application - Overview
    • 8.3.1 Table - Global Market by Application
    • 8.3.2 Chart - Global Market by Application - Base/Final Year Comparison
    • 8.3.3 Chart - Global Market by Application - Base Year
    • 8.3.4 Chart - Global Market by Application - Final Year
    • 8.3.5 Chart - Global Market by Application - Share by Year
    • 8.3.6 Chart - Global Market by Application - Segment Growth
  • 8.4 Global Market Size by Product - Overview
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Base/Final Year Comparison
    • 8.4.3 Chart - Global Market by Product - Base Year
    • 8.4.4 Chart - Global Market by Product - Final Year
    • 8.4.5 Chart - Global Market by Product - Share by Year
    • 8.4.6 Chart - Global Market by Product - Segment Growth

9 Global Market by Length

  • 9.1 <20 mer Market
    • 9.1.1 Table - <20 mer Market by Country
    • 9.1.2 Chart - <20 mer Market Segment Growth
  • 9.2 21-50 mer Market
    • 9.2.1 Table - 21-50 mer Market by Country
    • 9.2.2 Chart - 21-50 mer Market Segment Growth
  • 9.3 51-100 mer Market
    • 9.3.1 Table - 51-100 mer Market by Country
    • 9.3.2 Chart - 51-100 mer Market Segment Growth
  • 9.4 >100 mer Market
    • 9.4.1 Table - >100 mer Market by Country
    • 9.4.2 Chart - >100 mer Market Segment Growth

10 Global Market by Application

  • 10.1 Research Market
    • 10.1.1 Table - Research Market by Country
    • 10.1.2 Chart - Research Market Segment Growth
  • 10.2 Diagnostics Market
    • 10.2.1 Table - Diagnostics Market by Country
    • 10.2.2 Chart - Diagnostics Market Segment Growth
  • 10.3 Therapeutics Market
    • 10.3.1 Table - Therapeutics Market by Country
    • 10.3.2 Chart - Therapeutics Market Segment Growth
  • 10.4 Data Market
    • 10.4.1 Table - Data Market by Country
    • 10.4.2 Chart - Data Market Segment Growth

11 Global Market by Product

  • 11.1 Oligonucleotides Market
    • 11.1.1 Table - Oligonucleotides Market by Country
    • 11.1.2 Chart - Oligonucleotides Market Segment Growth
  • 11.2 Instruments Market
    • 11.2.1 Table - Instruments Market by Country
    • 11.2.2 Chart - Instruments Market Segment Growth
  • 11.3 Reagents Market
    • 11.3.1 Table - Reagents Market by Country
    • 11.3.2 Chart - Reagents Market Segment Growth

12 Appendices

  • 12.1 Typical Oligo Synthesis Price Lists
  • 12.2 Medicare Clinical Lab Fee Schedule
  • 12.3 Share of Pharma R&D by Country

Table of Tables

  • Table 1 Companies Formed to Exploit Enzyme Synthesis
  • Table 2 Market Players by Type
  • Table 3 Five Factors Driving Growth
  • Table 4 Three Factors Limiting Growth
  • Table 5 Global Market by Country/Region
  • Table 6 Global Market by Length
  • Table 7 Global Market by Application
  • Table 8 Global Market by Product
  • Table 9 <20 mer Market by Country
  • Table 10 21-50 mer Market by Country
  • Table 11 51-100 mer Market by Country
  • Table 12 >100 mer Market by Country
  • Table 13 Research Market by Country
  • Table 14 Diagnostics Market by Country
  • Table 15 Therapeutics Market by Country
  • Table 16 Data Market by Country
  • Table 17 Oligonucleotides Market by Country
  • Table 18 Instruments Market by Country
  • Table 19 Reagents Market by Country
  • Table 20 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Global Health Spending
  • Figure 2 The Lab Test Pie
  • Figure 3 Phosphoramidites Structure
  • Figure 4 DNA/Oligonucleotide Synthetic Cycle
  • Figure 5 The Road to Diagnostics
  • Figure 6 Growth rates of Oligionucleotide Synthesis by Application
  • Figure 7 Market Size by Country
  • Figure 8 Global Market by Length - Base vs. Final Year
  • Figure 9 Length Market Base Year
  • Figure 10 Length Market Final Year
  • Figure 11 Length Share by Year
  • Figure 12 Length Segment Growth
  • Figure 13 Global Market by Application - Base vs. Final Year
  • Figure 14 Application Market Base Year
  • Figure 15 Application Market Final Year
  • Figure 16 Application Share by Year
  • Figure 17 Application Segment Growth
  • Figure 18 Global Market by Product - Base vs. Final Year
  • Figure 19 Product Market Base Year
  • Figure 20 Product Market Final Year
  • Figure 21 Product Share by Year
  • Figure 22 Product Segment Growth
  • Figure 23 Chart - <20 mer Market Growth
  • Figure 24 Chart 21-50 mer Market Growth
  • Figure 25 Chart - 51-100 mer Market Growth
  • Figure 26 Chart - >100 mer Market Growth
  • Figure 27 Chart Research Market Growth
  • Figure 28 Chart - Diagnostics Market Growth
  • Figure 29 Chart - Therapeutics market Growth
  • Figure 30 Chart - Data Market Growth
  • Figure 31 Chart Oligonucleotides Market Growth
  • Figure 32 Chart - Instruments Market Growth
  • Figure 33 Chart - Reagents Market Growth
  • Figure 34 Eurofins Price List
  • Figure 35 Hokkaido System Science Co. Price List
  • Figure 36 Biobasic Price List
  • Figure 37 Share of Pharma R&D by Country